Amneal Pharmaceuticals

Amneal Pharmaceuticals received FDA approval for prednisolone acetate ophthalmic suspension 1%, a generic version of Allergan's Pred Forte for treating steroid-responsive ocular inflammation.

Amneal Pharmaceuticals reported Q1 2025 revenue of $695 million, a 5% year-over-year increase, with growth across all three business segments despite falling short of analyst expectations.

The FDA has approved Amneal Pharmaceuticals' Brekiya, the first and only dihydroergotamine (DHE) autoinjector for acute treatment of migraine and cluster headaches in adults.

Amneal Pharmaceuticals and Apiject Systems have formed a strategic collaboration to expand domestic production of sterile drug dosage forms using Blow-Fill-Seal technology at Amneal's Brookhaven, NY facility.

Jazz Pharmaceuticals will pay $145 million to settle allegations of anti-competitive practices related to its narcolepsy drug Xyrem, while denying all wrongdoing in the class action lawsuit.

New Phase 3 RISE-PD study data reveals CREXONT (carbidopa/levodopa extended-release) significantly improved sleep quality in Parkinson's disease patients compared to immediate-release formulations, with a mean difference of -2.35 in PDSS-2 scores (p<0.0001).

Amneal Pharmaceuticals and Shilpa Medicare have launched Boruzu, the first ready-to-use bortezomib formulation for subcutaneous or intravenous administration in multiple myeloma and mantle cell lymphoma treatment.

The U.S. District Court ordered Teva Pharmaceuticals to remove its ProAir HFA inhaler device patents from the FDA's Orange Book, ruling they don't meet statutory listing requirements.

Amneal Pharmaceuticals achieved Q4 2023 revenues of $730.52 million, marking an 18% year-over-year growth driven by strong performance across Affordable Medicines, AvKARE, and Specialty segments.

A comprehensive study of 1,058 NSCLC patients reveals bevacizumab biosimilars match the reference drug Avastin in overall response rates, with biosimilars achieving 27.41% compared to 29.79% for the original drug.